MetaADEDB 2.0 @ LMMD
Natamycin
(NCXMLFZGDNKEPB-BQGNJOPGSA-N)
Structure
SMILES
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](OC2O[C@H](C)[C@H]([C@@H]([C@@H]2O)N)O)C[C@@H]2O[C@@](C[C@H](C[C@@H]3[C@@H](/C=C/C(=O)O1)O3)O)(O)C[C@@H]([C@H]2C(=O)O)O
Molecular Formula:
C33H47NO13
Molecular Weight:
665.725
Log P:
0.8200
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
7
TPSA:
230.99
CAS Number(s):
7681-93-8
Synonym(s)
1.
Natamycin
2.
Pimaricin
3.
Tennecetin
4.
Myprozine
5.
Pimafucin
External Link(s)
MeSHD010866
PubChem Compound91820142
5281099
ChEBI7488
KEGGcpd:C08073
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 4US FAERS
2Eye painFAERS: 4US FAERS
3Medication residue presentFAERS: 4US FAERS
4Drug ineffectiveFAERS: 3US FAERS
5Corneal PerforationFAERS: 2US FAERS
6Foreign body sensation in eyesFAERS: 2US FAERS
7KeratitisFAERS: 2US FAERS
8Ocular discomfortFAERS: 2US FAERS
9Poor quality drug administeredFAERS: 2US FAERS
10Product solubility abnormalFAERS: 2US FAERS
11AspergillosisFAERS: 1US FAERS
12Expired product administeredFAERS: 1US FAERS
13Eye inflammationFAERS: 1US FAERS
14Liquid product physical issueFAERS: 1US FAERS
15Product depositFAERS: 1US FAERS
16Product physical issueFAERS: 1US FAERS
17Product quality issueFAERS: 1US FAERS
18SomnolenceFAERS: 1US FAERS
19Trigeminal NeuralgiaFAERS: 1US FAERS
20InflammationCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.